PharmEasy-Owned Thyrocare’s Q1 Profit Soars 34% To ₹51 Cr

•Thyrocare's consolidated net profit for Q1 FY27 rose 34% to ₹51.3 Cr from ₹38.3 Cr a year ago.

•Revenue from operations jumped 24.4% to ₹240 Cr during Q1 FY27 from ₹193 Cr in Q1 FY26.

•Diagnostic testing services contributed ₹226.2 Cr, accounting for over 94% of revenue, during Q1 FY27.

•Total expenses increased 19.8% to ₹176.6 Cr from ₹147.5 Cr a year ago, mainly due to higher employee costs and other expenses.

•Thyrocare served 54 Lakh patients and conducted 5.52 Cr tests during Q1 FY27, marking 17% and 28% YoY growth, respectively.